When should anticoagulation and antiplatelet therapy be initiated after thrombolytic treatment for acute myocardial infarction?

When to Start Anticoagulation and Antiplatelet After Thrombolysis in MI

Antiplatelet therapy should be initiated immediately with thrombolysis, while anticoagulation should be continued throughout and after PCI, with specific timing based on the anticoagulant used and whether PCI is performed.

Immediate Antiplatelet Therapy (Given WITH Thrombolysis)

Aspirin must be administered before or simultaneously with the fibrinolytic agent 1, 2:

• Loading dose: 162-325 mg orally (chewable, non-enteric coated) or 150-325 mg orally 3
• Alternative: 250-500 mg IV if oral route not feasible 1, 3
• Maintenance: 75-100 mg daily indefinitely 4

P2Y12 inhibitor timing depends on whether clopidogrel was given with fibrinolysis 1, 2:

If Clopidogrel Already Given With Fibrinolysis:

• Continue clopidogrel 75 mg daily without additional loading dose (Class I, Level C) 1, 2

If NO Prior Clopidogrel Loading:

The timing depends on when PCI is performed:

For PCI ≤24 hours after fibrinolysis:

• Clopidogrel 300 mg loading dose before or at time of PCI (Class I, Level C) 1, 2

For PCI >24 hours after fibrinolysis:

• Clopidogrel 600 mg loading dose before or at time of PCI (Class I, Level C) 1, 2
• Alternative: Prasugrel 60 mg at time of PCI if >24 hours after fibrin-specific agent or >48 hours after non-fibrin-specific agent (Class IIa, Level B) 1, 2
  • Contraindicated if prior stroke/TIA (Class III: Harm) 1, 2

Anticoagulation Management

Anticoagulation should be continued through PCI without interruption 1, 2:

Unfractionated Heparin (UFH):

• Continue through PCI with additional IV boluses to maintain therapeutic ACT (Class I, Level C) 1, 2
• Target ACT: 250-300 seconds (HemoTec) or 300-350 seconds (Hemochron) without GP IIb/IIIa inhibitors 1, 2

Enoxaparin:

• Continue through PCI (Class I, Level B) 1, 2:
  • No additional dose if last dose within 8 hours
  • 0.3 mg/kg IV bolus if last dose 8-12 hours earlier

Fondaparinux:

• Do NOT use as sole anticoagulant for PCI (Class III: Harm, Level C) 1, 2

Post-PCI Maintenance Therapy

Duration depends on stent type 1, 2:

Drug-Eluting Stent (DES):

• Continue dual antiplatelet therapy for at least 12 months (Class I) 4, 5, 6:
  • Clopidogrel 75 mg daily (Class I, Level C)
  • OR Prasugrel 10 mg daily (Class IIa, Level B)
  • OR Ticagrelor (preferred in newer guidelines) 4

Bare-Metal Stent (BMS):

• Continue dual antiplatelet therapy for at least 30 days and up to 12 months 1, 2:
  • Clopidogrel 75 mg daily (Class I, Level C)
  • OR Prasugrel 10 mg daily (Class IIa, Level B)

Critical Timing Pitfalls

1. Do NOT delay aspirin - it must be given with or before fibrinolysis, not after
2. Do NOT give additional clopidogrel loading if already loaded with fibrinolysis
3. Do NOT use fondaparinux alone during PCI - requires additional anticoagulation
4. Do NOT interrupt anticoagulation between fibrinolysis and PCI - continue through procedure
5. For prasugrel: verify no prior stroke/TIA and ensure adequate time has passed after fibrinolysis (>24 hours for fibrin-specific agents)

Special Considerations for Delayed PCI

If PCI performed 3-24 hours after successful fibrinolysis (Class IIa, Level B) 2:

• Follow same antiplatelet/anticoagulation protocols as above
• Timing of clopidogrel loading depends on whether given with initial fibrinolysis

The key principle: antiplatelet therapy starts immediately with thrombolysis, while anticoagulation continues seamlessly through any subsequent PCI without interruption.